Joinn Lab (昭衍新药) A+H Trading: Fall in A-Share Limits the Upside
In this note, we look at updates since our last note. We think the deal attracted strong demands but its upside is capped by its A-share prices.
262 Views
ECM Weekly (21 February 2021) - Tencent Lock-Up Expiry, SciClone Pharma, Joinn Lab, Bairong, Betta
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
561 Views
JOINN Laboratories IPO: Valuation Insights
JOINN has launched its HK IPO at an indicative price range of HK$133-151 per H-share. The combination of a reasonable AH discount and relative...
401 Views
Joinn Lab (昭衍新药) A+H: Visible Upside
There is clear upside from the high end with strong line-up of cornerstone investors. There will also be plenty of shares for institutional...
346 Views